Particle.news

Bayern Officials Question Jamal Musiala's Future and Contract

Club leaders say medical uncertainty over Musiala's treatable neurological condition and the cost of his long deal could force talks on his salary or a sale next year.

Overview

  • Musiala made a comeback as a late substitute in Bayern’s 1-1 draw with Cologne on Friday after roughly two months out with a muscle problem.
  • Karl‑Heinz Rummenigge and other senior figures have publicly suggested Musiala may not regain his prior level and said the club must consider renegotiating his pay or exploring a transfer if form does not return.
  • FIFPRO issued a formal rebuke, saying repeated public comments from Bayern’s hierarchy risk pressuring Musiala and breach the club’s duty of care to a recovering player.
  • Bayern president Herbert Hainer, sporting directors Max Eberl and coach Vincent Kompany have said the club’s priority is Musiala’s health and that he will receive support and time to recover.
  • Reports say managing Musiala’s medication is a major challenge because drugs that suppress his absence seizures can cause performance‑limiting side effects, and some outlets say a reported release clause could become active in 2027, which would affect transfer options next summer.